Novo Nordisk Dividends and Buybacks
Dividend criteria checks 3/6
Novo Nordisk is a dividend paying company with a current yield of 1.4% that is well covered by earnings.
Key information
1.4%
Dividend yield
0.7%
Buyback Yield
| Total Shareholder Yield | 2.1% |
| Future Dividend Yield | 2.5% |
| Dividend Growth | -5.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €9.900 |
| Payout ratio | 47% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: NNO2's dividend payments have been volatile in the past 10 years.
Growing Dividend: NNO2's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Novo Nordisk Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (NNO2) | 1.4% |
| Market Bottom 25% (AT) | 2.1% |
| Market Top 25% (AT) | 6.2% |
| Industry Average (Pharmaceuticals) | 2.6% |
| Analyst forecast (NNO2) (up to 3 years) | 2.5% |
Notable Dividend: NNO2's dividend (1.4%) isn’t notable compared to the bottom 25% of dividend payers in the Austrian market (2.06%).
High Dividend: NNO2's dividend (1.4%) is low compared to the top 25% of dividend payers in the Austrian market (6.21%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (46.6%), NNO2's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (65.4%), NNO2's dividend payments are covered by cash flows.